Women, power, and cancer: a Lancet Commission

O Ginsburg, V Vanderpuye, AM Beddoe, N Bhoo-Pathy… - The Lancet, 2023 - thelancet.com
Executive summary Women interact with cancer in complex ways, as healthy individuals
participating in cancer prevention and screening activities, as individuals living with and …

The expanding role of primary care in cancer control

G Rubin, A Berendsen, SM Crawford… - The lancet …, 2015 - thelancet.com
The nature of cancer control is changing, with an increasing emphasis, fuelled by public and
political demand, on prevention, early diagnosis, and patient experience during and after …

Screening for lung cancer: CHEST guideline and expert panel report

PJ Mazzone, GA Silvestri, S Patel, JP Kanne… - Chest, 2018 - Elsevier
Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States in the past few years, in large part due to the results of the National Lung …

Comorbid chronic diseases and cancer diagnosis: disease-specific effects and underlying mechanisms

C Renzi, A Kaushal, J Emery, W Hamilton… - Nature reviews clinical …, 2019 - nature.com
An earlier diagnosis is a key strategy for improving the outcomes of patients with cancer.
However, achieving this goal can be challenging, particularly for the growing number of …

Unmet supportive care needs associated with quality of life for people with lung cancer: A systematic review of the evidence 2007–2020

A Cochrane, S Woods, S Dunne… - European Journal of …, 2022 - Wiley Online Library
Introduction The aim of this review was to systematically examine the evidence on the
relationship between quality of life (QoL) and unmet supportive care needs in patients with …

Screening for lung cancer: CHEST guideline and expert panel report

PJ Mazzone, GA Silvestri, LH Souter, TJ Caverly… - Chest, 2021 - Elsevier
Background Low-dose chest CT screening for lung cancer has become a standard of care in
the United States, in large part because of the results of the National Lung Screening Trial …

Symptoms and patient factors associated with diagnostic intervals for pancreatic cancer (SYMPTOM pancreatic study): a prospective cohort study

FM Walter, K Mills, SC Mendonça, GA Abel… - The lancet …, 2016 - thelancet.com
Background Pancreatic cancer is the tenth most common cancer in the UK; however,
outcomes are poor, in part due to late diagnosis. We aimed to identify symptoms and other …

[HTML][HTML] Symptom signatures and diagnostic timeliness in cancer patients: a review of current evidence

MM Koo, W Hamilton, FM Walter, GP Rubin… - Neoplasia, 2018 - Elsevier
Early diagnosis is an important aspect of contemporary cancer prevention and control
strategies, as the majority of patients are diagnosed following symptomatic presentation. The …

Diagnosing cancer earlier: reviewing the evidence for improving cancer survival.

SC Hiom - British journal of cancer, 2015 - nature.com
Diagnosing cancer earlier: reviewing the evidence for improving cancer survival | British Journal
of Cancer Skip to main content Thank you for visiting nature.com. You are using a browser …

Capmatinib for the treatment of non-small cell lung cancer

JF Vansteenkiste, C Van de Kerkhove… - Expert review of …, 2019 - Taylor & Francis
Introduction: Activation of the MET pathway through MET amplifications or mutations is
present in 3–4% of stage IV non-squamous non-small cell lung cancers (NSCLC). High MET …